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Abstract 
Purpose: To clarify the effect of manipulating intratumor hypoxia on 
radiosensitivity under reduced dose-rate (RDR) irradiation. 
Methods: Tumor-bearing mice were continuously given 
5-bromo-2’-deoxyuridine (BrdU) to label all proliferating (P) cells. 
They received -rays or accelerated carbon-ion beams at high dose-rate 
(HDR) or RDR with or without tumor clamping to induce hypoxia. Some 
mice without clamping received nicotinamide, an acute hypoxia-releasing 
agent or misonidazole, a hypoxic cell radio-sensitizer before 
irradiation. The responses of quiescent (Q) and total (= P+Q) cells 
were assessed by the micronucleus frequency using immunofluorescence 
staining for BrdU. 
Results: The clearer decrease in radiosensitivity in Q than total cells 
after RDR -ray irradiation was suppressed with carbon-ion beams, 
especially with a higher linear energy transfer value. Repressing the 
decrease in the radiosensitivity under RDR irradiation through keeping 
tumors hypoxic during irradiation and enhancing the decrease in the 
radiosensitivity by nicotinamide were clearer with -rays and in total 
cells than with carbon-ion beams and in Q cells, respectively. Inhibiting 
the decrease in the radiosensitivity by misonidazole was clearer with 
-rays and in Q cells than with carbon-ion beams and in total cells, 
respectively. 
Conclusion: Manipulating hypoxia during RDR as well as HDR irradiation 
influences tumor radiosensitivity, especially with -rays. 
 
Key words: 
Dose-rate effect; Manipulating hypoxia; Quiescent cell; Carbon-ion 
beams; -Rays 
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Introduction 
Intensity modulated radiotherapy (IMRT) and stereotactic 
irradiation have become common as a new radiotherapy technique for 
treatment of malignancies. Both modalities generally use multiple arc 
or fixed-portal radiation beams, and radiation beams are exposed 
intermittently. These techniques often require 30 min or a longer time 
in one treatment session for precise positioning of patients.
1,2
 
Prolongation of irradiation time may reduce a radiation effect, and 
evokes a major concern for the dose rate effect. Thus, it is needed 
to clarify the effect of the reduction of dose rate on the 
radiosensitivity of tumors in vivo. 
When using low linear energy transfer (LET) radiation, lowering 
the dose rate is thought to reduce late effects in normal tissue much 
more than it decreases tumor control. Thus, the “therapeutic ratio” 
increases as the dose rate decreases, because the therapeutic ratio 
is equal to the ratio of tumor control to normal tissue complications. 
Further, the difference between early and late effects for low dose-rate 
radiotherapy, as well as improving the therapeutic ratio, allows 
complete treatment in a short period of time, minimizing the effects 
of tumor repopulation. In other words, decreasing the dose rate 
increases the therapeutic ratio, limited only by tumor cell 
repopulation.
3
 This is the primary rationale for low dose-rate 
radiotherapy using low LET radiation. High LET radiation is more 
effective than low LET X- or -radiation at inducing biologic damage. 
High LET radiation results in a greater relative biological 
effectiveness (RBE) value for cell killing, a reduced oxygen effect, 






































































Manipulating hypoxia in solid tumors during irradiation apparently 
influences tumor radiosensitivity under high dose-rate (HDR) 
irradiation using low LET radiation.
5
 However, its significance in solid 
tumors irradiated at a reduced dose rate (RDR) is less clear in vivo, 
whether low or high LET radiation is employed. 
Many cells in solid tumors are quiescent in situ but still 
clonogenic.
6
 The quiescent (Q) tumor cells are more resistant to low-LET 
radiation because of their larger hypoxic fraction and greater capacity 
to recover from potentially lethal damage (PLD) than proliferating (P) 
tumor cells. The rationale for low dose-rate radiotherapy does not take 
into account the response of Q tumor cells at all. 
Thus, in this study, we tried to elucidate the effect of 
manipulating hypoxia in irradiated solid tumors at a RDR with low-LET 
-rays or high-LET 290 MeV/u accelerated carbon-ion beams in vivo, 
compared with HDR irradiation. Further, the responses of the total (= 
P + Q) and Q cell populations in irradiated solid tumors were separately 
detected with the method for selectively detecting the response of Q 
cells within solid tumors.
7
 This is the first attempt to clarify the 
direct relationship between the irradiation dose rate effect and the 
oxygen effect in vivo, referring to the response of the Q cell population 
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Materials and Methods 
Mice and tumors 
SCC VII squamous cell carcinoma cell line derived from C3H/He mice 
was maintained in vitro in Eagle’s minimum essential medium 
supplemented with 12.5 % fetal bovine serum. The tumor cells (1.0 x 
10
5
) were inoculated subcutaneously into the left hind leg of 9-week-old 
syngeneic female C3H/He mice (Japan Animal Co., Ltd., Osaka, Japan). 
Fourteen days later, the tumors, approximately 1 cm in diameter, were 
employed for experimental treatment, and the body weight of the 
tumor-bearing mice was 22.1 ± 2.3 (Mean ± SD) g. Mice were handled 
according to the Recommendations for Handling of Laboratory Animals 
for Biomedical Research, compiled by the Committee on Safety Handling 
Regulations for Laboratory Animal Experiments. Incidentally, the p53 
of SCC VII tumor cells is the wild type.
7
 
Labeling with 5-bromo-2’-deoxyuridine (BrdU) 
Nine days after the inoculation, mini-osmotic pumps (Durect 
Corporation, Cupertino, CA) containing BrdU dissolved in physiological 
saline (250 mg/ml) were implanted subcutaneously to label all P cells 
for 5 days. The percentage of labeled cells after continuous labeling 
with BrdU was 55.3 ± 4.5 %, and reached a plateau at this stage. Therefore, 
tumor cells not incorporating BrdU after continuous labeling were 
regarded as Q cells. 
Treatment 
After the labeling with BrdU, tumor-bearing mice received -ray or 
accelerated carbon-ion whole-body irradiation, with the animal held 
in a specially designed device made of acrylic resin with the tail or 
all four legs firmly fixed with adhesive tape with no anesthetic. Some 
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before irradiation.
7
 This clamping for 15 min did not influence 
clonogenic cell survival or the level of micronucleation. 
-Rays were delivered with a cobalt-60 -ray irradiator at a dose 
rate of 2.5 or 0.039 Gy/min. 
Carbon-12 ions were accelerated up to 290 MeV/u by the synchrotron 
of the Heavy Ion Medical Accelerator installed at National Institute 
of Radiological Sciences in Chiba, Japan. The dose rate was regulated 
through a beam attenuation system, and irradiation was conducted using 
horizontal carbon beams with a dose rate of 1.0 or 0.035 Gy/min. The 
LET of the carbon ion beam with the 6-cm spread-out Bragg peak (SOBP) 
ranges from 14 keV/µm to greater than 200 keV/µm, depending on depth. 
A desired LET beam was obtained by selecting the depth along the beam 
path using a Lucite range shifter. An LET of 18 and 50 keV/µm at the 
middle of the plateau and the SOBP were employed here, respectively.
8
 
Irradiated tumor-bearing mice were divided into 4 groups. I) Tumors 
were excised immediately after irradiation only under aerated 
conditions. II) Tumors were kept totally hypoxic during irradiation, 
then excised immediately after irradiation. III) The tumor-bearing mice 
received an intraperitoneal administration of an acute 
hypoxia-releasing agent, nicotinamide (1000 mg/kg of mouse weight) 
dissolved in physiological saline 60 min before irradiation, then the 
tumors were excised immediately after irradiation under aerated 
conditions. IV) The tumor-bearing mice received an intraperitoneal 
administration of a hypoxic cell radio-sensitizer, misonidazole (1000 
mg/kg of mouse weight) dissolved in physiological saline 30 min before 
irradiation, then the tumors were excised immediately after irradiation 
under aerated conditions. All the doses employed, sequences and timing 






































































Each treatment group also included mice not pretreated with BrdU. 
Immunofluorescence staining of BrdU-labeled cells and micronucleus (MN) 
assay 
Tumors excised from the mice given BrdU were minced and trypsinized 
[0.05% trypsin and 0.02% ethylenediamine-tetraacetic acid (EDTA) in 
phosphate-buffered saline (PBS), 37 °C, 20 min]. Tumor cell suspensions 
were incubated for 72 h in tissue culture dishes containing complete 
medium and 1.0 µg/ml of cytochalasin-B to inhibit cytokinesis while 
allowing nuclear division, and the cultures were then trypsinized and 
cell suspensions were fixed. After the centrifugation of fixed cell 
suspensions, the cell pellet was resuspended with cold Carnoy’s fixative 
(ethanol:acetic acid = 3:1 in volume). The suspension was placed on 
a glass microscope slide and the sample was dried at room temperature. 
The slides were treated with 2 M hydrochloric acid for 60 min at room 
temperature to dissociate the histones and partially denature the DNA. 
The slides were immersed in borax-borate buffer (pH 8.5) to neutralize 
the acid. BrdU-labeled tumor cells were detected by indirect 
immunofluorescence staining using a monoclonal anti-BrdU antibody 
(Becton Dickinson, San Jose, CA) and a fluorescein isothiocyanate 
(FITC)-conjugated antimouse IgG antibody (Sigma, St. Louis, MO). To 
observe the double staining of tumor cells with green-emitting FITC 
and red-emitting propidium iodide (PI), cells on the slides were treated 
with PI (2 µg/ml in PBS) and monitored under a fluorescence microscope. 
The MN frequency in cells not labeled with BrdU could be examined 
by counting the micronuclei in the binuclear cells that showed only 
red fluorescence. The MN frequency was defined as the ratio of the number 
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cells observed.
7
  The MN frequency has already been shown to be a tool 
for detecting radiosensitivity to carbon-ion beams.
11
 
The ratios obtained in tumors not pretreated with BrdU indicated 
the MN frequency at all phases in the total tumor cell population. More 
than 400 binuclear cells were counted to determine the MN frequency. 
Clonogenic cell survival assay 
The clonogenic cell survival assay was also performed in the mice 
given no BrdU using an in vivo-in vitro assay method. Tumors were 
disaggregated by stirring for 20 min at 37 °C in PBS containing 0.05 % 




As stated above, the MN frequencies for Q cells were obtained from 
non-labeled tumor cells after continuous BrdU labeling. The MN 
frequencies and surviving fractions for the total cell population were 
obtained from cells in tumors not pretreated with BrdU. Thus, there was 
no effect of interaction between BrdU and irradiation on the values of 
MN frequency and SF. More than 3 tumor-bearing mice were used to assess 
each set of conditions and each experiment was repeated at least twice. 
To examine the differences between pairs of values, Student’s t-test 
was used when variances of the two groups could be assumed to be equal; 
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Results 
The plating efficiency and MN frequency at 0 Gy are shown in Table 
1. The plating efficiency was significantly smaller for the combination 
with MISO than for any other condition in the total cell population. 
In both the total and Q cell populations, the MN frequency significantly 
increased in the following order: absolute control < totally hypoxic 
conditions < combination with nicotinamide < combination with 
misonidazole. Further, the MN frequency was significantly higher for 
Q cell population than the total cell population under all conditions. 
Cell survival curves for the total tumor cells as a function of 
radiation dose after -ray irradiation are shown in Figure 1. For both 
HDR and RDR irradiation, the surviving fractions (SFs) decreased in the 
following order: irradiation under totally hypoxic conditions > aerobic 
irradiation without any drug > irradiation after nicotinamide loading 
> irradiation after misonidazole loading. The SFs under all conditions 
increased as the dose rate of radiation decreased, especially after 
nicotinamide loading. 
Cell survival curves for the total tumor cells as a function of 
radiation dose after accelerated carbon-ion beam irradiation with an 
LET of 18 and 50 keV/µm are shown in the left and right panels of Figure 
2, respectively. For both HDR and RDR irradiation, the SFs decreased 
in the same order as for -ray irradiation, but the degree of change 
was reduced, especially with 50 keV/µm carbon-ion beams. The increases 
in the SF with the decrease in dose rate were suppressed compared with 
-ray irradiation, again especially with 50 keV/µm carbon-ion beams. 
For baseline correction, we used the normalized MN frequency to 
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frequency was the MN frequency in the irradiated tumors minus that in 
the non-irradiated tumors. Dose response curves of the normalized MN 
frequency for total and Q tumor cell populations as a function of 
radiation dose after -ray irradiation are shown in the left and right 
panels of Figure 3, respectively. Overall, the normalized MN frequencies 
were significantly smaller in Q cells than the total cells. In both total 
and Q cells, under RDR as well as HDR irradiation, the normalized MN 
frequencies increased in the following order: irradiation under totally 
hypoxic conditions < aerobic irradiation without drugs < irradiation 
after nicotinamide loading < irradiation after misonidazole loading. 
The normalized MN frequencies decreased with the decrease in dose rate 
under all conditions, especially irradiation after nicotinamide loading 
in the total cell population. 
Dose response curves of the normalized MN frequency for the total 
and Q tumor cells as a function of radiation dose after accelerated 
carbon-ion beam irradiation with an LET of 18 (Figure 4) or 50 keV/µm 
(Figure 5) are shown in the left and right panels, respectively. Overall, 
the normalized MN frequencies were significantly smaller in Q cells than 
total cells, but the differences in radiosensitivity between the total 
and Q cells were reduced compared with -ray irradiation, especially 
with 50 keV/µm carbon-ion beams. In both the total and Q cells, under 
RDR as well as HDR irradiation, the normalized MN frequencies increased 
in the same order as for -ray irradiation, but the degree of change 
was reduced, especially with 50 keV/µm carbon-ion beams. The decreases 
in the normalized MN frequency with the decrease in radiation dose rate 
were suppressed compared with -ray irradiation, again especially with 
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To estimate the effect of aerobic irradiation compared with hypoxic 
irradiation in both the total and Q cells, the data for aerobic 
irradiation without any drug and irradiation under totally hypoxic 
conditions were used (Table 2). Following -ray irradiation, the values 
were significantly smaller for Q cells than the total cells (P < 0.05), 
and in both the total and Q cells, the values were significantly smaller 
for RDR than HDR irradiation (P < 0.05). In both populations, carbon-ion 
beams produced significantly smaller values than -rays (P < 0.05), and 
the values approached to 1.0 as the LET values increased. 
To assess the radio-enhancing effect of nicotinamide or 
misonidazole under aerobic conditions in both the total and Q cells 
compared with aerobic irradiation without any drug, the data for aerobic 
irradiation with and without drugs were used (Table 3). The enhancing 
effect of nicotinamide was more marked in the total cell population, 
especially with HDR -ray irradiation. The effect was little observed 
for RDR -ray irradiation and accelerated carbon-ion irradiation 
especially with a higher LET value. In contrast, the enhancing effect 
of misonidazole was more marked in the Q cells. The enhancing effect 
was also attenuated for accelerated carbon-ion irradiation especially 
with a higher LET value. 
To investigate the reduction in radiosensitivity caused by a 
decrease in radiation dose rate, dose-modifying factors were calculated 
using the data for all irradiation conditions given in Figures 1 through 
5 (Table 4). On the whole, the reduction in radiosensitivity was more 
marked in Q than the total cells, especially under -ray irradiation. 
In the total cells, the degree of the reduction of radiosensitivity was 
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> aerobic irradiation without any drug > aerobic irradiation with 
misonidazole > irradiation under totally hypoxic conditions. In Q cells, 
the degree of the reduction of radiosensitivity was reduced in the 
following order: aerobic irradiation with nicotinamide = aerobic 
irradiation without any drug > irradiation under totally hypoxic 
conditions > aerobic irradiation with misonidazole. This order of the 
reduction in radiosensitivity and the difference in the reduction in 
radiosensitivity between Q and the total cells became more indistinct 
with the use of accelerated carbon-ion beams, especially at a higher 
LET value, than with the use of -rays. 
To examine the difference in radiosensitivity between the total 
and Q cells, dose-modifying factors, which allow us to compare the dose 
of radiation necessary to obtain a normalized MN frequency of 0.2 in 
Q cells with that in the total cells, were calculated using the data 
in Figures 2 and 3 (Table 5). Overall, the difference in radiosensitivity 
was greater under RDR than HDR irradiation, especially with -rays. The 
difference in radiosensitivity increased in the following order: 
irradiation under totally hypoxic conditions < aerobic irradiation with 
misonidazole < aerobic irradiation without any drug ≤ aerobic 
irradiation with nicotinamide. This order of the increase in the 
difference in radiosensitivity and the difference itself in 
radiosensitivity became more indistinct with the use of accelerated 
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Discussion 
Solid tumors, especially human tumors, are thought to contain a 
high proportion of Q cells.
6
 The presence of Q cell is probably due, 
in part, to hypoxia and the depletion of nutrients in the tumor core, 
another consequence of poor vascular supply.
6
 This might promote the 
formation of micronuclei at 0 Gy in Q tumor cells (Table 1). Q cells 
were shown to have significantly less radiosensitivity than the total 
cells here (Figs. 3 through 5). This means that more Q cells survive 
radiation therapy than P cells. Thus, the control of Q cells has a great 
impact on the outcome of radiation therapy. In both the total and Q 
cell populations, carbon ion irradiation was less dependent on 
oxygenation status with little recovery from radiation-induced DNA 
damage, leading to high RBE values compared with -ray irradiation.
11
 
In terms of the tumor cell-killing effect as a whole, including 
intratumor Q cell control, carbon-ion beam radiotherapy can be a 
promising treatment for refractory tumors. 
Q cell population had been shown to include a significantly larger 
hypoxic fraction than the total cell population,
12
 resulting in a 
significantly smaller effect of carbon-ion beams under aerobic 
irradiation compared with hypoxic irradiation in Q cells (Table 2). 
Since tumor radiosensitivity was significantly less dependent on 
intratumor oxygenation status and the irradiation dose rate effect when 
carbon-ion beams, especially with a higher LET value, were used, a much 
smaller effect of aerobic irradiation compared with hypoxic irradiation 
was observed here. This was partly because the frequency of closely 
spaced DNA lesions forming a cluster of DNA damage produced by high 
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Tumor hypoxia is a direct consequence of structural abnormalities 
of the microvasculature and functional abnormalities of the 
microcirculation in solid tumors and results from either limited oxygen 
diffusion (chronic hypoxia) or limited perfusion (acute hypoxia, 
transient hypoxia, or ischemic hypoxia). Large intercapillary distances 
resulting from rapid tumor cell proliferation lead to chronically 
hypoxic cells existing at the rim of the oxygen diffusion distance.
14
 
Factors such as vessel plugging by blood cells or circulating tumor 
cells, the collapse of vessels in regions of high tumor interstitial 
pressure, or spontaneous vasomotor activity in normal tissue vessels 
incorporated into the tumor which subsequently affects flow in 
downstream tumor microvessels cause intermittent blood flow in tumors, 
which results in acute hypoxia.
15
 Thus, acute hypoxic areas are 
distributed throughout the tumor depending on these causative factors 
and can occur sporadically in large areas of a solid tumor. Nicotinamide, 
a vitamin B
3
 analogue, is known to prevent these transient fluctuations 
in tumor blood flow that lead to the development of acute hypoxia.
9
 
Misonidazole is a typical 2-nitro-imidazole hypoxic cell sensitizer 
which is thought to function as an oxygen-mimicking agent in intratumor 
hypoxic areas under irradiation.
10
 In SCC VII tumors, it had been shown 
that the hypoxic fraction of the total cell population is predominantly 
made up of acute hypoxic areas and that of the hypoxia rich-Q cell 
population is mainly made up of chronic hypoxic areas.
12
 Therefore, under 
HDR -ray irradiation, the enhancement ratio of nicotinamide was higher 
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in the Q cells (Table 3). When carbon-ion beams, especially with a higher 
LET value, were employed, these differences in the enhancement ratio 
were reduced because radiosensitivity was much less dependent on 
intratumor oxygenation status.
11
 However, under RDR -ray irradiation, 
acute hypoxic areas appear and disappear throughout a solid tumor during 
long periods of irradiation.
15
 As a result, RDR irradiation even without 
nicotinamide could make it possible to irradiate all acute hypoxic areas 
under oxic conditions, leading to no radio-enhancing effect of 
nicotinamide. The radio-enhancing effect of misonidazole, which depends 
on the size of the hypoxic fraction in solid tumors, however, still 
could be observed under RDR as well as HDR irradiation. 
Enhancement of the irradiation dose rate effect on the normalized 
frequency of micronuclei by -ray irradiation in the presence of 
nicotinamide compared with -ray irradiation alone was observed in the 
acute hypoxia-rich total cells rather than the chronic hypoxia-rich 
Q cells (Table 4). Suppression of the dose rate effect by inducing total 
hypoxia during irradiation was slightly more clearly observed in 
normoxia-rich total cell than hypoxia-rich Q cells. Some recent studies 
in vitro found that hypoxia-induced translational repression can 
explain the decreased homologous recombination (HR) repair of 
radiation-induced DNA double-stranded breaks (dsbs),
16
 a more important 
mechanism for the repair of dsbs in late-S and G2, and that HR plays 
a greater role in determining hypoxic radiosensitivity than normoxic 
radiosensitivity.
17
 Thus, the use of nicotinamide or tumor clamping to 
induce total hypoxia influenced repair more in the total cells including 
late-S and G2 phase cells than in Q cells. In contrast, the repression 
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misonidazole was slightly more clearly observed in the hypoxia-rich 
Q cells than normoxia-rich total cells. It had already been shown that 
the loading of misonidazole after low LET HDR irradiation to solid tumors 
inhibited the recovery from radiation-induced PLD in vivo, especially 
in Q cells.
18
 In this study, it was shown that misonidazole combined 
with low LET RDR irradiation could suppress the dose rate effect, 
especially in Q cells. According to the previous finding that the 
recovery from PLD and the decrease in radiosensitivity through a 
reduction in the irradiation dose rate under low LET irradiation are 
mainly due to non-homologous end-joining (NHEJ) repair, which is the 
predominant DNA dsbs repair process for cells in G0, G1 or early-S phase,
19
 
misonidazole itself or protein adducts of reductively-activated 
misonidazole in hypoxic areas in irradiated tumors may inhibit NHEJ 
more efficiently than HR.
10
 Again, when carbon-ion beams, especially 
with a higher LET value, were employed, the effects of combined treatment 
on the irradiation dose rate effect became indistinct because 
radiosensitivity was much less dependent on intratumor oxygenation 
status and the irradiation dose rate.
11
 
Overall, the difference in radiosensitivity between the total and 
Q cells was increased by reducing the dose rate, especially for -ray 
irradiation, because of the greater reduction in radiosensitivity 
caused by a decrease in the dose rate in Q cells than in the total cells
9
 
(Table 5). Nicotinamide enhanced the radiosensitivity of the total cells, 
leading to a widening of the difference in radiosensitivity between 
the total and Q cell populations compared with aerobic HDR -ray 
irradiation without any drug. But, for RDR -ray irradiation, the effect 
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in solid tumors, resulting in no change in the difference in 
radiosensitivity between the total and Q cells compared with -ray 
irradiation only. Meanwhile, under totally hypoxic conditions, the 
difference in radiosensitivity was smaller than for aerobic -ray 
irradiation because of the radio-resistance induced by total hypoxia 
in both the total and Q cell populations in sold tumors. Misonidazole 
enhanced the radiosensitivity of the hypoxia-rich Q cells much more 
than that of the total cells under both HDR and RDR -ray irradiation, 
leading to a decrease in the difference in radiosensitivity between 
the two cells compared with aerobic -ray irradiation only. When 
carbon-ion beams, especially with a higher LET value, were employed, 
the effects of combined treatment on the difference in radiosensitivity 
between the total and Q cells became indistinct because tumor 
radiosensitivity was much less dependent on intratumor oxygenation 
status and the irradiation dose rate.
11
 Anyway, at least in this study, 
it was elucidated that manipulating hypoxia during RDR irradiation, 
especially with -rays, influences tumor radiosensitivity as well as 
HDR irradiation in both total and Q cell populations. In radiotherapy, 
irradiation dose rate also should be taken into account when intratumor 
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Captions for Illustrations 
Fig. 1. Cell survival curves for the total tumor cell population as 
a function of radiation dose after -ray irradiation. Open and 
solid symbols represent the surviving fractions after high 
dose-rate and reduced dose-rate -ray irradiation, 
respectively. Circles, reversed triangles, triangles, and 
squares represent the surviving fractions after aerobic 
irradiation without any drug, irradiation under totally 
hypoxic conditions, aerobic irradiation after nicotinamide 
(NA) loading, and aerobic irradiation after misonidazole 
(MISO) loading, respectively. Bars represent standard errors. 
Fig. 2. Cell survival curves for the total tumor cell population as 
a function of radiation dose after accelerated carbon-ion beam 
irradiation with an LET of 18 and 50 keV/µm are shown in the 
left and right panels, respectively. Open and solid symbols 
represent the surviving fractions after high dose-rate and 
reduced dose-rate accelerated carbon-ion beam irradiation, 
respectively. Circles, reversed triangles, triangles, and 
squares represent the surviving fractions after aerobic 
irradiation without any drug, irradiation under totally 
hypoxic conditions, aerobic irradiation after nicotinamide 
(NA) loading, and aerobic irradiation after misonidazole 
(MISO) loading, respectively. Bars represent standard errors. 
Fig. 3. Dose response curves of the normalized micronucleus frequency 
for the total and quiescent tumor cell populations as a 
function of radiation dose after -ray irradiation are shown 
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symbols represent the normalized micronucleus frequencies 
after high dose-rate and reduced dose-rate -ray irradiation, 
respectively. Circles, reversed triangles, triangles, and 
squares represent the normalized micronucleus frequencies 
after aerobic irradiation without any drug, irradiation under 
totally hypoxic conditions, aerobic irradiation after 
nicotinamide (NA) loading, and aerobic irradiation after 
misonidazole (MISO) loading, respectively. Bars represent 
standard errors. 
Fig. 4. Dose response curves of the normalized micronucleus frequency 
for the total and quiescent tumor cell populations as a 
function of radiation dose after accelerated carbon-ion beam 
irradiation with an LET of 18 keV/µm are shown in the left and 
right panels, respectively. Open and solid symbols represent 
the normalized micronucleus frequencies after high dose-rate 
and reduced dose-rate accelerated carbon-ion beam irradiation, 
respectively. Circles, reversed triangles, triangles, and 
squares represent the normalized micronucleus frequencies 
after aerobic irradiation without any drug, irradiation under 
totally hypoxic conditions, aerobic irradiation after 
nicotinamide (NA) loading, and aerobic irradiation after 
misonidazole (MISO) loading, respectively. Bars represent 
standard errors. 
Fig. 5. Dose response curves of the normalized micronucleus frequency 
for the total and quiescent tumor cell populations as a 
function of radiation dose after accelerated carbon-ion beam 
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right panels, respectively. Open and solid symbols represent 
the normalized micronucleus frequencies after high dose-rate 
and reduced dose-rate accelerated carbon-ion beam irradiation, 
respectively. Circles, reversed triangles, triangles, and 
squares represent the normalized micronucleus frequencies 
after aerobic irradiation without any drug, irradiation under 
totally hypoxic conditions, aerobic irradiation after 
nicotinamide (NA) loading, and aerobic irradiation after 
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Table 1. 
 
Plating efficiency and micronucleus frequency at 0 Gy 
__________________________________________________________________ 
 Total tumor cells Quiescent cells 
__________________________________________________________________ 
<Plating efficiency (%)> 
Absolutely control 53.7 ± 8.5
a
 ---- 
Totally hypoxic 50.1 ± 7.0 ---- 
+ Nicotinamide 46.8 ± 0.6 ---- 
+ Misonidazole 31.2 ± 7.7  
 
<Micronucleus frequency> 
Absolutely control 0.043 ± 0.005 0.063 ± 0.009 
Totally hypoxic 0.058 ± 0.006 0.073 ± 0.010 
+ Nicotinamide 0.073 ± 0.009 0.119 ± 0.014 
+ Misonidazole 0.093 ± 0.011 0.152 ± 0.018 
__________________________________________________________________ 
a
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Table 2. 
 
Irradiation under aerobic conditions 




 -Rays Carbon-ion beams Carbon-ion beams 
  (18 keV/µm) (50 keV/µm) 
__________________________________________________________________ 
<Surviving fraction = 0.3> 
Total cells 
    High dose-rate irradiation 
 2.1 (2.0-2.2)
b
 1.4 (1.3-1.5) 1.15 (1.1-1.2) 
    Reduced dose-rate irradiation 
 1.8 (1.7-2.0) 1.25 (1.15-1.35) 1.1 (1.05-1.15) 
 
<Normalized micronucleus frequency = 0.2> 
Total cells 
High dose-rate irradiation 
 1.9 (1.8-2.0) 1.35 (1.25-1.45) 1.2 (1.1-1.3) 
Reduced dose-rate irradiation 
 1.7 (1.6-1.8) 1.25 (1.15-1.35) 1.15 (1.1-1.2) 
Quiescent cells 
High dose-rate irradiation 
 1.5 (1.4-1.6) 1.25 (1.15-1.35) 1.15 (1.1-1.2) 
Reduced dose-rate irradiation 
 1.3 (1.2-1.4) 1.1 (1.05-1.15) 1.05 (1.0-1.1) 
__________________________________________________________________ 
a
; The ratio of the dose of radiation necessary to obtain each end-point 
under hypoxic conditions to that needed to obtain each end-point under 
aerobic conditions. 
b
; Values in parentheses are 95% confidence limits, determined using 
standard errors. If the ranges of 95 % confidence limits showed no 
overlap between any two values, the difference between the two values 







































































 due to combination 
with nicotinamide or misonidazole 
__________________________________________________________________ 
  High dose rate Reduced dose rate 
  irradiation irradiation 
__________________________________________________________________ 
<Surviving fraction = 0.3> 
Total cells 
 -Rays 
   + Nicotinamide 1.3 (1.2-1.4)
b
 1.05 (1.0-1.1) 
   + Misonidazole 1.8 (1.6-2.0) 1.85 (1.7-2.0) 
 Carbon-ion beams (18 keV/µm) 
   + Nicotinamide 1.15 (1.1-1.2) 1.05 1.0-1.1) 
   + Misonidazole 1.3 (1.2-1.4) 1.35 (1.3-1.4) 
 Carbon-ion beams (50 keV/µm) 
   + Nicotinamide 1.05 (1.0-1.1) 1.05 (1.0-1.1) 
   + Misonidazole 1.1 (1.05-1.15) 1.15 (1.1-1.2) 
 
<Normalized micronucleus frequency = 0.2> 
Total cells 
-Rays 
   + Nicotinamide 1.2 (1.1-1.3) 1.05 (1.0-1.1) 
   + Misonidazole 1.3 (1.2-1.4) 1.35 (1.25-1.45) 
 Carbon-ion beams (18 keV/µm) 
   + Nicotinamide 1.15 (1.1-1.2) 1.05 (1.0-1.1) 
   + Misonidazole 1.2 (1.1-1.3) 1.25 (1.15-1.35) 
 Carbon-ion beams (50 keV/µm) 
   + Nicotinamide 1.05 (1.0-1.1) 1.05 (1.0-1.1) 
   + Misonidazole 1.05 (1.0-1.1) 1.05 (1.0-1.1) 
Quiescent cells 
-Rays 
   + Nicotinamide 1.1 (1.05-1.15) 1.05 (1.0-1.1) 
   + Misonidazole 1.45 (1.35-1.55) 1.5 (1.4-1.6) 
 Carbon-ion beams (18 keV/µm) 
   + Nicotinamide 1.05 (1.0-1.1) 1.0 (0.95-1.05) 
   + Misonidazole 1.25 (1.15-1.35) 1.3 (1.2-1.4) 
 Carbon-ion beams (50 keV/µm) 
   + Nicotinamide 1.05 (1.0-1.1) 1.0 (0.95-1.05) 
   + Misonidazole 1.1 (1.05-1.15) 1.1 (1.05-1.15) 
__________________________________________________________________ 
a
; The ratio of the dose of radiation necessary to obtain each end-point 
without the drug to that needed to obtain each end-point with the 
drug. 
b
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Table 4. 
 
Dose-modifying factors due to the reduction in radiosensitivity caused 




 -Rays Carbon-ion beams Carbon-ion beams 
  (18 keV/µm) (50 keV/µm) 
__________________________________________________________________ 
<Surviving fraction = 0.3> 
Total cells 
   Radiation only 
 1.3 (1.2-1.4)
b
 1.2 (1.1-1.3) 1.15 (1.1-1.2) 
   Totally hypoxic 
 1.2 (1.1-1.3) 1.15 (1.05-1.25) 1.1 (1.05-1.15) 
   + Nicotinamide 
 1.55 (1.4-1.7) 1.35 (1.25-1.45) 1.2 (1.15-1.25) 
   + Misonidazole 
 1.25 (1.15-1.35) 1.2 (1.1-1.3) 1.15 (1.1-1.2) 
 
<Normalized micronucleus frequency = 0.2> 
Total cells 
   Radiation only 
 1.25 (1.15-1.35) 1.2 (1.1-1.3) 1.1 (1.05-1.15) 
   Totally hypoxic 
 1.15 (1.1-1.2) 1.1 (1.05-1.15) 1.05 (1.0-1.1) 
   + Nicotinamide 
 1.4 (1.25-1.55) 1.3 (1.2-1.4) 1.2 (1.1-1.3) 
   + Misonidazole 
 1.2 (1.1-1.3) 1.15 (1.05-1.25) 1.1 (1.05-1.15) 
Quiescent cells 
   Radiation only 
 1.4 (1.3-1.5) 1.3 (1.2-1.4) 1.25 (1.15-1.35) 
   Totally hypoxic 
 1.25 (1.15-1.35) 1.15 (1.1-1.2) 1.1 (1.05-1.15) 
   + Nicotinamide 
 1.4 (1.3-1.5) 1.3 (1.2-1.4) 1.25 (1.15-1.35) 
   + Misonidazole 
 1.15 (1.1-1.2) 1.1 (1.05-1.15) 1.1 (1.05-1.15) 
__________________________________________________________________ 
a
; The ratio of the dose of radiation necessary to obtain each end-point 
with reduced dose-rate irradiation to that needed to obtain each 
end-point with high dose-rate irradiation. 
b
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Table 5. 
 
Dose-modifying factors for quiescent cells 




 -Rays Carbon-ion beams Carbon-ion beams 
  (18 keV/µm) (50 keV/µm) 
__________________________________________________________________ 
<Normalized micronucleus frequency = 0.2> 
High dose rate irradiation 
   Radiation only 
 1.65 (1.5-1.8)
b
 1.45 (1.35-1.55) 1.35 (1.25-1.45) 
   Totally hypoxic 
 1.4 (1.15-1.55) 1.3 (1.2-1.4) 1.25 (1.15-1.35) 
   + Nicotinamide 
 1.75 (1.6-1.9) 1.5 (1.4-1.6) 1.4 (1.3-1.5) 
   + Misonidazole 
 1.5 (1.35-1.65) 1.35 (1.25-1.45) 1.3 (1.2-1.4) 
Reduced dose rate irradiation 
   Radiation only 
 1.85 (1.7-2.0) 1.6 (1.5-1.7) 1.5 (1.4-1.6) 
   Totally hypoxic 
 1.45 (1.35-1.55) 1.35 (1.25-1.45) 1.3 (1.2-1.4) 
   + Nicotinamide 
 1.85 (1.7-2.0) 1.6 (1.5-1.7) 1.5 (1.4-1.7) 
   + Misonidazole 
 1.55 (1.45-1.65) 1.4 (1.3-1.5) 1.35 (1.25-1.45) 
__________________________________________________________________ 
a
; The ratio of the dose of radiation necessary to obtain each normalized 
micronucleus frequency in quiescent cell population to that needed 
to obtain each normalized micronucleus frequency in total tumor cell 
population. 
b
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